Distinct Effects of Omeprazole and Rabeprazole on the Tacrolimus Blood Concentration in a Kidney Transplant Recipient-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Distinct Effects of Omeprazole and Rabeprazole on the Tacrolimus Blood Concentration in a Kidney Transplant Recipient

Published:2007 Issue:6 Volume:22 Page:441-444
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Takahashi Kazushige,Yano Ikuko,Fukuhara Yuga,Katsura Toshiya,Takahashi Takeshi,Ito Noriyuki,Yamamoto Shingo,Ogawa Osamu,Inui Ken-ichi

Publisher

Japanese Society for the Study of Xenobiotics

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference17 articles.

1. A prospective randomized trial of tacrolimus-based immunosuppression after renal transplantation;Shapiro;Transplantation,1995

2. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole;Andersson;Clin. Pharmacokinet.,1996

3. Review article: cytochrome P450 and the metabolism of proton pump inhibitors-emphasis on rabeprazole;Ishizaki;Aliment. Pharmacol. Ther.,1999

4. Interaction between omeprazole and tacrolimus in renal allograft recipients: a clinical-analytical study;Pascual;Transplant. Proc.,2005

5. Interaction between tacrolimus and omeprazole in a pediatric liver transplant recipient;Moreau;Transplantation,2006

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of omeprazole and famotidine effects on the pharmacokinetics of tacrolimus in patients following kidney transplant–randomized controlled trial;Frontiers in Pharmacology;2024-04-04

2. Safety analysis of co-administering tacrolimus and omeprazole in renal transplant recipients – A review;Biomedicine & Pharmacotherapy;2023-10

3. Importance of Pharmacogenetics and Drug–Drug Interactions in a Kidney Transplanted Patient;Life;2023-07-26

4. Investigation of pharmacologic interactions between omeprazole and tacrolimus in a membranous nephropathy patient with CYP3A5 nonexpresser: a case report;Pharmacogenetics and Genomics;2022-07-25

5. Inhibition of Cytochrome P450 Enzyme and Drug-Drug Interaction Potential of Acid Reducing Agents Used in Management of CDK Inhibitors for Breast Cancer Chemotherapy;Current Drug Metabolism;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3